CA Stock MarketDetailed Quotes
MRVL Marvel Biosciences Corp
- 0.115
- 0.0000.00%
15min DelayMarket Closed Jul 18 16:00 ET
4.58MMarket Cap-1916P/E (TTM)
0.120High0.115Low3.50KVolume0.120Open0.115Pre Close412.00Turnover0.19052wk High0.01%Turnover Ratio39.79MShares0.01052wk Low-0.06EPS TTM3.82MFloat Cap0.390Historical HighLossP/E (Static)33.21MShs Float0.010Historical Low-0.06EPS LYR4.35%Amplitude--Dividend TTM-1.67P/B1Lot Size--Div YieldTTM
Marvel Biosciences Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -21.56%-359.98K | -0.72%-239.31K | 32.10%-239.64K | 39.28%-1.33M | -0.33%-445.56K | -37.19%-296.14K | 81.14%-237.6K | -28.78%-352.93K | -60.07%-2.19M | 21.29%-444.11K |
| Net income from continuing operations | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K | 78.22%-232.99K | 41.94%-296.2K | 15.96%-2.55M | 72.12%-581.89K |
| Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -17.84%152 | --0 |
| Remuneration paid in stock | -66.33%4.5K | -64.84%7.05K | -70.50%9.69K | --80.12K | --13.82K | --13.37K | --20.06K | --32.86K | --0 | --0 |
| Change In working capital | -114.34%-57.17K | 45.07%-13.55K | 400.24%268.97K | 144.14%879.04K | 331.63%594.67K | 125.95%398.63K | 87.03%-24.67K | -137.94%-89.58K | 414.14%360.05K | 152.98%137.77K |
| -Change in receivables | 25.05%-6.79K | 30.06%-8.3K | -234.49%-10.76K | -1,054.87%-25.48K | -48.50%-12.55K | -137.43%-9.06K | 79.33%-11.86K | -81.95%8K | 111.47%2.67K | 31.11%-8.45K |
| -Change in prepaid assets | -91.88%10.7K | 71.22%-7.43K | -4.16%8.76K | 192.70%230.04K | 147.70%114.9K | 1,908.12%131.81K | ---25.81K | --9.14K | -1,475.53%-248.15K | -1,429.24%-240.86K |
| -Change in payables and accrued expense | -122.14%-61.08K | -83.30%2.17K | 353.88%270.96K | 11.39%674.47K | 27.19%492.32K | 72.95%275.88K | 109.79%13K | -155.64%-106.73K | 900.96%605.53K | 266.84%387.08K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -21.56%-359.98K | -0.72%-239.31K | 32.10%-239.64K | 39.28%-1.33M | -0.33%-445.56K | -37.19%-296.14K | 81.14%-237.6K | -28.78%-352.93K | -60.07%-2.19M | 21.29%-444.11K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 500K | 0 | 228.85%1.3M | 0 | 1M | 0 | 295.65K | -87.52%394K | -83.91%394K |
| Net issuance payments of debt | --0 | ---- | ---- | --1M | --0 | --1M | ---- | ---- | --0 | ---- |
| Net common stock issuance | --0 | --0 | --0 | -35.71%270K | -107.14%-30K | --0 | --0 | --300K | -87.03%420K | -83.88%420K |
| Net other financing activities | ---- | ---- | ---- | 198.65%25.65K | --30K | --0 | --0 | ---4.35K | 87.41%-26K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --500K | --0 | 228.85%1.3M | --0 | --1M | --0 | --295.65K | -87.52%394K | -83.91%394K |
| Net cash flow | ||||||||||
| Beginning cash position | 93.64%577.67K | -40.85%316.98K | -6.17%556.62K | -75.21%593.21K | 55.78%1M | -65.28%298.33K | -74.71%535.93K | -75.21%593.21K | 964.52%2.39M | 407.71%643.32K |
| Current changes in cash | -151.14%-359.98K | 209.72%260.69K | -318.37%-239.64K | 97.97%-36.59K | -789.12%-445.56K | 426.08%703.86K | 81.14%-237.6K | 79.10%-57.28K | -183.01%-1.8M | -102.21%-50.11K |
| End cash Position | -78.28%217.69K | 93.64%577.67K | -40.85%316.98K | -6.17%556.62K | -6.17%556.62K | 55.78%1M | -65.28%298.33K | -74.71%535.93K | -75.21%593.21K | -75.21%593.21K |
| Free cash from | -21.56%-359.98K | -0.72%-239.31K | 32.10%-239.64K | 39.28%-1.33M | -0.33%-445.56K | -37.19%-296.14K | 81.14%-237.6K | -28.78%-352.93K | -60.07%-2.19M | 21.29%-444.11K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg